Acorn Financial Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Acorn Financial Advisory Services’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$937K	Sell	1,502 -1	-0.1%	-$681	0.12%	90
2026 Q1	$1.16M	Hold	1,503	–	–	0.16%	68
2025 Q4	$1.16M	Buy	1,503 +1	+0.1%	+$679	0.17%	61
2025 Q3	$845K	Hold	1,502	–	–	0.13%	79
2025 Q2	$789K	Hold	1,502	–	–	0.13%	78
2025 Q1	$953K	Sell	1,502 -100	-6%	-$68.8K	0.17%	68
2024 Q4	$1.14M	Hold	1,602	–	–	0.19%	62
2024 Q3	$1.68M	Sell	1,602 -1	-0.1%	-$1.11K	0.3%	37
2024 Q2	$1.68M	Hold	1,603	–	–	0.31%	35
2024 Q1	$1.54M	Buy	1,603 +1	+0.1%	+$951	0.29%	43
2023 Q4	$1.41M	Buy	1,602 +2	+0.1%	+$1.65K	0.25%	61
2023 Q3	$1.32M	Hold	1,600	–	–	0.24%	63
2023 Q2	$1.15M	Buy	+1,600	New	+$1.23M	0.2%	71

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Acorn Financial Advisory Services's REGN Position: Q2 2026 in Review

Acorn Financial Advisory Services reduced its Regeneron Pharmaceuticals (REGN) stake by 0.07% in Q2 2026, selling an estimated $681 and leaving 1,502 shares worth $937K. The position accounts for 0.12% of the portfolio, ranked #90.

Acorn Financial Advisory Services first reported a position in REGN in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.68M in Q2 2024. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Acorn Financial Advisory Services held 1,502 shares of Regeneron Pharmaceuticals worth $937K as of Q2 2026.
Acorn Financial Advisory Services sold 1 Regeneron Pharmaceuticals share in Q2 2026, an estimated $681.
Regeneron Pharmaceuticals made up 0.12% of Acorn Financial Advisory Services's portfolio in Q2 2026, its #90 holding.
Acorn Financial Advisory Services first reported a position in Regeneron Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
Acorn Financial Advisory Services's Regeneron Pharmaceuticals position peaked at $1.68M in Q2 2024.
1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Acorn Financial Advisory Services's 13F filing for Q2 2026, filed 20 Jul 2026.